Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. htmd

HTMD

Feasibility assessment of a cloud application platform for rational drug design using high throughput molecular dynamics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 HTMD project word cloud

Explore the words cloud of the HTMD project. It provides you a very rough idea of what is the project "HTMD" about.

acellera    computationally    subsequent    leader    silico    clinical    significantly    resolution    biological    industry    demonstration    drugs    discovery    molecular    computational    ready    sme    reduce    pharmaceutical    progress    launch    drug    platform    environment    beginning    accurate    larger    complexity    substantially    identification    inform    instrument    unprecedented    looks    speed    traction    proprietary    1000m    accuracy    uniquely    disruptive    description    dynamics    positioned    proposes    solution    interactions    pcr    viability    barrier    htmd    interact    rational    proposing    gain    companies    workflows    translating    approximately    resource    combines    degree    unnecessary    approved    optimized    market    pace    preparations    spending    simulation    feasibility    trl    candidate    cloud    expensive    invest    md    simulations    virtualizing    limits    competitiveness    interfaces    throughput    entry    provides    productivity    prototyping    global   

Project "HTMD" data sheet

The following table provides information about the project.

Coordinator		 ACELLERA LABS SL 

Organization address
address: C/ DELS PINZON 19 2-4
city: BARCELONA
postcode: 8003
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACELLERA LABS SL ES (BARCELONA) coordinator 50˙000.00

Map

 Project objective

The pharmaceutical industry’s increasing spending on R&D is not translating into new and better drugs at the pace required to maintain competitiveness. In-silico computational methods are beginning to gain traction in the progress towards more rational drug discovery workflows. Among the methods available, molecular dynamics (MD) provides the most accurate and useful description of molecular interactions, but the current state of the art has both a high degree of unnecessary technical complexity, and is computationally expensive. Together, these two factors have produced a high barrier to entry that substantially limits research productivity.Acellera looks to address these issues by proposing a cloud application platform for high-throughput MD (HTMD) simulations. This computational platform combines proprietary simulation technology - optimized for speed and simulation throughput – and user-friendly interfaces in a cloud environment to provide a novel resource for drug candidate identification. HTMD, which allows understanding with an unprecedented degree of resolution and accuracy how drugs interact with their biological targets, can significantly reduce the cost of pre-clinical research (PCR) by virtualizing key steps. It is currently estimated that pharmaceutical companies invest approximately 1000M Euro per approved drug. As a global leader in the development of technology for high-throughput molecular dynamics, Acellera is uniquely positioned to bring this disruptive computational technology to the market. The HTMD platform is ready for prototyping in an operational environment (TRL 6). Acellera proposes a Phase 1 SME Instrument to support the execution of a feasibility study into the market viability of the HTMD solution for pre-clinical research. Results of the study will be used to inform preparations for a larger-scale demonstration in Phase 2 and for the subsequent market launch.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HTMD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HTMD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Assist (2015)

Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone

Read More  

Demographica (2017)

Helping marketing campaigns go viral

Read More  

MicroSpot (2018)

The first portable, low-cost, robotized scanner microscope that converts any smartphone into a high quality and intelligent tele-microscopy image diagnosis system

Read More